Venous thromboembolism in 2013: the advent of the novel oral anticoagulants
- PMID: 24419256
- DOI: 10.1038/nrcardio.2013.210
Venous thromboembolism in 2013: the advent of the novel oral anticoagulants
Abstract
New findings published in 2013 strongly support the use of novel oral anticoagulants in the treatment of thromboembolic disorders. These drugs have been shown to have a more-favourable benefit-to-risk profile than older compounds, enabling their use from the start of treatment and in the whole spectrum of clinical presentations.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
